Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2026-01-11 @ 12:58 AM
Study NCT ID:
NCT03855358
Status:
UNKNOWN
Last Update Posted:
2019-10-30
First Post:
2019-02-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC)
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-09
Start Date Type:
ACTUAL
Primary Completion Date:
2020-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-02-25
First Submit QC Date:
None
Study First Post Date:
2019-02-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-29
Last Update Post Date:
2019-10-30
Last Update Post Date Type:
ACTUAL